Process and Product Development Subcommittee


The Process and Product Development Subcommittee strives to:

  • Establish and communicate best practices in Process and Product Development (PPD) as it relates to therapeutic cell based products.
  • Assess emerging cell processing technologies and forecast their impact on the commercialization process.

Click here to view the full charter.

Projects and Objectives

  • Educational Webinars: Process Development is a discipline learned on the job and there are few texts that cover many of the best practices used in the field—and fewer available that discuss Cell Therapy-specific requirements. The Process and Product Development Subcommittee develops educational webinars to cover best practices in Cell Therapy Process Development. Click here to view upcoming webinars.
  • White papers: White papers are an important vehicle for the PPD to educate and influence the field. White papers will be published in peer-reviewed journals to increase credibility and visibility of the PPD and ISCT. Click here to view the published PPD white papers.
  • ISCT Annual Meeting: The PPD will be actively involved in the organization of the ISCT Annual Meeting. At least one session in the Strategies for Commercialization Track will be organized by this committee.




Committee Chair


Dominic Clarke, PhD
Winston Salem, NC, United States

John Fink, MBA
Pall Corporation
Boston, MA, United States


Committee Members


Sasha Aleksic, MSc
FUJIFILM Irvine Scientific
Irvine, CA, United States

Julie Allickson, PhD, MSc, MT(ASCP)
Wake Forest Institute for Regenerative Medicine
Winston-Salem, NC, United States

Hyalker Amaral, MBA
Terumo BCT
Denver, CO, United States
Behnam Ahmadian Baghbaderani, PhD
Lonza Walkersville
Walkersville, MD, United States
Harvey Brandwein, PhD
Cook Myosite
New York, NY, United States
Christopher Bravery, PhD
Advanced Biologicals Ltd.
London, United Kingdom
Soenke Brunswieck, PhD
Celonic AG
Basel, Switzerland

Scott Burger, MD
Advanced Cell & Gene Therapy
Chapel Hill, NC, United States

Shannon Eaker, PhD
Knoxville, TN, United States

David Fiorentini, MSc
Biological Industries
Beit-Haemek, Israel

Maya Fuerstenau-Sharp, PhD
Sartorius-Stedim Biotech
Gottingen, Germany

Clive Glover, PhD
Pall Life Sciences
Portsmouth, United Kingdom


Heidi Hagen, MS, MBA
Seattle, WA, United States

Jack Hench
Durham, NC, United States
Robert Jones
London, United Kingdom
Ohad Karnieli, PhD, MBA
Adva Biotechnology
Haifa, Israel
Christopher Keller
Warren, NJ, United States

Julie Kerby, PhD
Cell & Gene Therapy Catapult
London, United Kingdom


Alex Lyness, PhD
West Pharmaceutical Services
Exton,PA, United States

Mark Leonard
San Francisco, CA, United States
Kara Levine, PhD
Bedford, MA, United States
Lexan Lhu, MSc
PBS Biotech
Cambridge, MA, United States
Yonatan Lipsitz, PhD
Sana Therapeutics 
Boston, MA, United States
Michael Mendicino, PhD
Hybrid Concepts International, LLC
Grand Island, NY, United States

Grace O'Connell, PhD
UC Berkeley
Berkely, CA, United States
Steve Oh, PhD
Jean-Sébastien Parisse, MBA
Aseptic Technologies
Gembloux, Belgium
Shabnum Patel, PhD
Stanford University, Center for Cancer Cell Therapy
Stanford, CA, United States
Ulrike Rehn, PhD
Thermo Fisher Scientific
Buffalo, NY, United States
Janet Rothberg
Toronto, ON, Canada
Alaina Schlinker, PhD
Lake Zurich, IL, United States

Michael Scott, PhD
BlueRock Therapeutics
Toronto, ON, Canada

Robert Sassa
WL Gore & Associates
Exton, MD, United States

David Smith, PhD
Hitachi Chemical Advanced Therapeutic Solutions (HCATS)
Allendale, NJ, United States




Jean-Sébastien Parisse
Asceptic Technologies
Isnes, Belgium

© 2020 ISCT. All rights reserved. 
ISCT, INTERNATIONAL SOCIETY FOR CELLULAR THERAPY and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy